In a unanimous decision, an FDA advisory committee recently determined that phenylephrine, a key ingredient in popular over-the-counter nasal decongestants, is no more effective than a placebo in treating cold and allergy symptoms. The committee reviewed mounting evidence indicating that oral phenylephrine is an ineffective remedy for nasal congestion, even though many consumers use products that contain it, such as Sudafed PE and NyQuil. In response, CVS retail pharmacies discontinued the sale of products containing …
Read More









